T.0340 Blood Transfusion Automation Managed Service Contract for Betsi Cadwaladr University Health Board

The public procurement process led by the Betsi Cadwaladr University Health Board involves a direct award contract for a Blood Transfusion Automation Managed Service, with Ortho Clinical Diagnostics as the supplier. This contract, initially established in 2016, comes under the healthcare services industry category and is regulated by both the MHRA and BSQR guidelines. Although initially due to expire in November 2026 following a 7-year term with a 3-year extension, the Health Board must delay the procurement of a new service due to resource constraints linked to the WLIMS system implementation.

The contract is set to be in force from December 2026 to November 2027, with a possible further six-month extension. Located primarily in various regions across Wales, the regulatory environment necessitates the careful execution of this heavily regulated contract. The procurement stage is currently in the award phase, with a significant date to note being the scheduled future signature by September 2025.

This contract presents an opportunity for businesses specialising in pathology services and blood transfusion technology to grow their presence in the healthcare sector. While the current contract has been directly awarded to Ortho Clinical Diagnostics due to complex regulatory considerations and existing supplier relationships, future procurement processes may provide opportunities for other companies once the current constraints are alleviated. Large-scale businesses with the capability to operate within strict regulatory frameworks would be well-suited to compete in this environment, offering innovative solutions that enhance patient safety and efficiency in transfusion services.